The Human Frontier Science Program (HFSP) funds innovative research work in the field of life sciences. The organization's members are Australia, Canada, France, Germany, Great Britain, India, Italy, Japan, New Zealand, Norway, South Korea, Switzerland and the USA, as well as the EU. Research grants are awarded to international research collaborations that carry out interdisciplinary work in order to develop cutting edge approaches to fundamental issues in the life sciences.
Oxidized lipidomes: Key figures in non-apoptotic cell death
Oxidative modifications of lipids are a key process in non-apoptotic cell death signalling and play important roles in a number of relevant diseases, such as neurodegeneration, diabetes and asthma. A team of scientists headed by Dr. Marcus Conrad from the Institute of Developmental Genetics (IDG) at the Helmholtz Zentrum Mnchen (HMGU) now strives to intensify research into the underlying molecular mechanisms. The overall goal of this program is to identify the specific signature of oxidized lipids and to decipher the interaction of these modified lipids with signal molecules that ultimately promote non-apoptotic cell death. Knowledge gained by this approach should lead to the development of a language code that, in turn, may provide cues for the design of novel treatment strategies. The partners in the project are Dr. Valerian Kagan, University of Pittsburgh (USA), Dr. Fulvio Ursini, University of Padova (Italy) and Dr. Judith Klein-Seetharaman, Warwick Medical School, Coventry (UK).
Mechanosensation: transmission and perception of neuronal stimuli
Movement and coordination must be modulated according to the environment. They are subject to permanent feedback from the perceived stimuli and adequate adaptive responses. With respect to the perceived signals, it is necessary to distinguish between external influences and self-generated stimuli a capability that makes highly differenti
|Contact: Press Office|
Helmholtz Zentrum Mnchen - German Research Center for Environmental Health